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A B S T R A C T
Objectives: The present review provides information about which molecules appear to be the main fluorophores
in skin and oral mucosa, together with their clinical applications.
Design: The MEDLINE database was searched, using “oral mucosa AND fluorophores”, “skin AND fluorophores”,
“epidermal AND fluorophores”, “dermal AND fluorophores” and “cutaneous AND fluorophores” as entry terms.
We searched the literature following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines. The level of evidence in the studies was assessed using the Classification of the Oxford
Centre for Evidence-based Medicine (CEBM) Levels for Diagnosis.
Results: Five papers and 17 were primarily focused on description of fluorophores in oral mucosa and skin
Evidence exists that fluorophores of oral mucosa and skin are mainly proteins such as collagen, elastin, keratin
and tryptophan. Other possible fluorophores identified are: porphyrins, advanced glycation end products, fla-
vins, lipopigment, nicotinamide adenine dinucleotide, flavin adenine dinucleotide, pheomelanin, eumelanin and
components of lipofuscin.
Clinical applications of oral mucosal autofluorescence (AF) are related to management of malignant and
potentially malignant lesions. In the skin, AF has been used for acne assessment, diagnosis of sweat-gland
pathologies, glycemic control and management of malignant lesions and as a marker for skin aging.
Conclusion: Fluorophores stimulated through AF devices are implied in different physiologic and pathologic
processes. AF seems to be useful for several clinical applications, especially in skin department.
Because most of the studies show a low level of evidence, further studies are necessary in such a promising
and fascinating field.
1. Introduction
Fluorophores are molecules that can absorb and re-emit specific
wavelengths of light and are therefore responsible for the phenomenon
of fluorescence.
Fluorophores can be classified into endogenous, when produced
within the body, and exogenous, if they originate from outside the or-
ganism. Endogenous fluorophores are either intracellular or extra-
cellular, both the cause of biological tissue autofluorescence (AF). AF is
defined as a peculiar visual property of some tissues directly associated
with the concentration and distribution of specific fluorophores. A
diagram illustrating the excitation of molecules and the following
phenomenon of fluorescence (Jablonski diagram) is shown in Fig. 1.
Cells and extracellular compartments within dysplastic and malig-
nant lesions may display modifications of the amount, distribution and
physicochemical properties of some endogenous fluorophores (Monici,
2005). Malignant and potentially malignant changes may therefore
result in AF variations, potentially useful for diagnostic purposes
(Fig. 2).
AF evaluation might improve the sensitivity and specificity of
cancer diagnosis, having been tested on several organs, such as colon,
lung, cervix and oesophagus (Schantz, Savage, Sacks, & Alfano, 1997).
Evidence has recently emerged that supports the usefulness of AF for
head and neck cancer diagnosis, at both the mucosal and cutaneous
levels (Monici, 2005; Schantz et al., 1997).
However, even though some fluorophores have been identified and
https://doi.org/10.1016/j.archoralbio.2019.07.001
Received 26 March 2019; Received in revised form 1 July 2019; Accepted 2 July 2019
⁎ Corresponding author.
E-mail address: ilaria.giovannacci@gmail.com (I. Giovannacci).
Archives of Oral Biology 105 (2019) 89–98
0003-9969/ © 2019 Published by Elsevier Ltd.
T
described in detail, there is currently a gap of knowledge about other
specific molecules responsible for tissue AF as well as about the me-
chanisms through which they cease to emit fluorescence in cases of
malignant or pre-malignant lesions (Schantz et al., 1997).
The present review provides information about which molecules
show evidence of being the main fluorophores in skin and oral mucosa,
together with their excitation and emission wavelengths and the de-
vices used for inducing fluorescence, as well as a discussion of clinical
applications of AF.
1.1. Methods for the literature search
The MEDLINE database was searched, using “oral mucosa AND
fluorophores”, “skin AND fluorophores”, “epidermal AND fluor-
ophores”, “dermal AND fluorophores” and “cutaneous AND fluor-
ophores” as entry terms.
To avoid accidental loss of relevant studies, we searched the lit-
erature following the Preferred Reporting Items for Systematic Reviews
and Meta-Analysis (PRISMA) statement published in 2009 (Moher,
Liberati, & Tetzlaff, 2009).
Reference lists of reviews were screened to identify papers poten-
tially not identified in the database search.
1.1.1. Study selection and data extraction
1.1.1.1. Inclusion criteria
- Papers focused on identification and characterisation of endogenous
fluorophores, reporting studies performed in in vivo (humans, ani-
mals), ex vivo and in vitro models
- No time limits
1.1.1.2. Exclusion criteria
- Papers with unavailable abstract
- Papers not in English language
- Congress proceedings
- Review papers
- Papers not clearly detailing the fluorophores investigated
- Papers not indicating excitation wavelength used for inducing
fluorescence
- Studies evaluating fluorescence induced by exogenous fluorophores
A PRISMA flow diagram was used to summarise the study selection
process. The flowchart followed for selection of studies of oral mucosa
is shown in Fig. 3. The flowchart for selection of studies on fluorophores
in skin is shown in Fig. 4.
The level of evidence in the studies was assessed using the
Classification of the Oxford Centre for Evidence-based Medicine
(CEBM) Levels for Diagnosis, updated in March 2009.
Fig. 1. Jablonski diagram, showing the molecular mechanism underlying the phenomenon of autofluorescence.
Fig. 2. Oral verrucous carcinoma surrounded by dysplastic tissue in a 65-year-old female patient. (a) clinical view; (b) fluorescence view.
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2. Fluorophores of oral mucosa
Five papers evaluating fluorophores in oral mucosa were identified
(Fig. 3) (Gurushankar, Nazeer, Jayasree, & Krishnakumar, 2015;
Jayanthi et al., 2009; Lane et al., 2006; Nazeer, Asish, Venugopal,
Anita, & Gupta, 2014; Vedeswari, Jayachandran, & Ganesan, 2009).
Molecules identified as fluorophores of the oral mucosa are: col-
lagen, the reduced form of nicotinamide, adenine dinucleotide (NADH),
flavin, adenine dinucleotide (FAD), porphyrins, elastin and keratin.
Specific data extracted from each study is shown in Table 1.
Collagen, NADH and FAD were indicated as fluorophores in four
studies, porphyrins in two studies and elastin and keratin in one study.
Excitation wavelengths used for the identification of the pre-
sumptive fluorophores ranged from 320 to 460 nm (including ultra-
violet [UV] radiations). Instead, the emission spectra ranged from 350
to 750 nm.
2.1. Reported clinical applications
Data on clinical applications was available in all five of the studies
selected for the present review.
In two studies AF was investigated as a potential aid for improving
cancer diagnostic accuracy (excitation wavelength used: 400–460 nm)
(Jayanthi et al., 2009; Lane et al., 2006). In one study, AF spectroscopy
was used for monitoring the therapeutic response and for characterising
tissue reaction after treatment of oral submucous fibrosis (excitation
wavelength used: 330 nm) (Vedeswari et al., 2009). Another study
demonstrated a variation in AF spectra between the oral mucosa of
habitual tobacco users and the oral mucosa of a group of volunteers
without any habits (excitation wavelength used: 410 nm) (Nazeer et al.,
2014).
In the only animal study identified, fluorescence spectroscopy was
proposed for monitoring or potentially predicting response to cancer
therapy (excitation wavelength used: 320 nm) (Gurushankar et al.,
2015).
2.2. Level of evidence
Four out of the five studies on oral mucosa and fluorophores were in
vivo studies, performed on humans. One study was a randomised trial in
an animal model (Gurushankar et al., 2014). The Oxford CEBM and
National Institutes of Health (NIH) Quality Assessment classifications
were therefore applicable for four studies (Jayanthi et al., 2009; Lane
et al., 2006; Nazeer et al., 2014; Vedeswari et al., 2009).
Level of evidence was 2b for all studies evaluated.
3. Fluorophores of skin
Fifteen papers were identified by using “Skin AND Fluorophores” as
entry terms, five papers by using “Epidermal AND Fluorophores” and
one paper by using “Dermal AND Fluorophores”. Four papers were
repetitions. The database search using “Cutaneous AND Fluorophores”
as entry terms did not identify papers dealing with the topic of the
present review. Seventeen papers were eventually included (Fig. 4)
(Breunig, Studier, & König, 2010; Dimitrow, Riemann et al., 2009,
2009b; Eny et al., 2015; Gillies, Zonios, Anderson, & Kollias, 2000;
Krasieva et al., 2013; Laiho, Pelet, Hancewicz, Kaplan, & So, 2005;
Leupold et al., 2011; Miyamoto & Kudoh, 2013; McMullen, Chen, &
Moore, 2012; Na, Stender, Henriksen, & Wulf, 2011; Patalay et al.,
2011; Richter, Trojahn, Dobos, Blume-Peytavi, & Kottner, 2016;
Stirban, Nandrean, Negrean, Koschinsky, & Tschoepe, 2008; Sandby-
Møller, Thieden, Philipsen, Heydenreich, & Wulf, 2004; Yu et al., 2012;
Zhao et al., 2016).
Molecules identified as possible fluorophores in the skin were por-
phyrins, advanced glycation end products (AGEs), flavins, lipopigment,
the reduced form of nicotinamide adenine dinucleotide (NADH), flavin
adenine dinucleotide (FAD), pheomelanin, eumelanin, collagen, elastin,
tryptophan, components of lipofuscin and keratin. Details of studies and
molecules are shown in Table 2.
Excitation wavelengths used for inducing AF ranged from 260 to
1000 nm (including UV). Wavelengths used with two-photon tomo-
graphy and femtosecond laser ranged from 720 to 1000 nm.
Wavelengths used with other devices ranged from 260 to 488 nm.
3.1. Reported clinical applications
Clinical applications of skin AF displayed a great heterogeneity.
In four of the selected studies, skin AF was proposed as a possible
new diagnostic tool for malignant melanoma. In all these papers, a two-
photon tomography instrument was the device used for investigation
(Dimitrow, Riemann et al., 2009, 2009b; Krasieva et al., 2013;
Miyamoto & Kudoh, 2013).
In two out of 17 papers, skin AF was investigated as a marker for
photo-aging, using UV wavelengths (330 and 370 nm) (Na et al., 2011;
Sandby-Møller et al., 2004).
Other applications reported for skin AF were measurement of acne
severity (excitation wavelength: 400 nm) (Richter et al., 2016); diag-
nosis and therapy of eccrine sweat gland disease (excitation wave-
length: 488 nm) (Zhao et al., 2016); screening for patients with un-
detected diabetes or cardiovascular risk (excitation wavelength used:
300–420 nm) and assessment of the effectiveness of anti-proliferative
agents (excitation wavelength used: 260–480 nm) (Gillies et al., 2000;
Stirban et al., 2008).
3.2. Level of evidence
Seven out of 17 studies on skin/epidermal fluorophores were in vivo
studies performed on humans; four out of 17 studies selected were ex
vivo and in vivo studies, and six out of 17 studies were ex vivo or in vitro
studies (Breunig et al., 2010; Dimitrow, Riemann et al., 2009, 2009b;
Eny et al., 2015; Gillies et al., 2000; Krasieva et al., 2013; Leopold et al.,
2011; McMullen et al., 2012; Na et al., 2011; Patalay et al., 2011;
Richter et al., 2016; Stirban et al., 2008; Laiho et al., 2005; Sandby-
Møller et al., 2004; Yu et al., 2012; Zhao et al., 2016).
The Oxford CEBM guidelines were applicable in 11 studies (Breunig
et al., 2010; Dimitrow, Riemann et al., 2009, 2009b; Eny et al., 2015;
Fig. 3. Flowchart reporting the selection procedures for papers on oral mucosa.
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Gillies et al., 2000; Miyamoto & Kudoh, 2013; McMullen et al., 2012;
Na et al., 2011; Richter et al., 2016; Stirban et al., 2008; Sandby-Møller
et al., 2004).
The level of evidence was 1b for one study, 2b for six studies and 3b
for four studies.
4. Commercial devices used to induce and visualise fluorescence
Commercial devices reported in the literature are usually based on
simple setups, (e.g., peculiar excitation and emission wavelength bands,
obtained by using excitation light sources [light editing diode LED]).
Such devices have been optimised for specific applications, (e.g.,
Visiopor© (Courage+Khazaka Electronic GmbH, Germany), including
the quantitative measurement of the AF emitted by bacterial porphyrins
in patients with acne (Richter et al., 2016).
A qualitative analysis of tissue AF is possible through devices similar
to those described. The VELscopeTM system (LED Medical Diagnostics
Inc., Barnaby, Canada) has been widely employed for diagnostic pur-
poses, particularly for oral mucosa.
Other devices are based on multi-photon tomography (e.g.,
DermaInspec© [JenLab GmbH, Germany]). The technique, used for in
vivo non-invasive tomography of human skin (Breunig et al., 2010;
Dimitrow, Riemann et al., 2009, 2009b; Miyamoto & Kudoh, 2013;
Patalay et al., 2011), is based on the near-infrared femto laser beam
scanning technology. Devices employing multi-photon tomography
allow optical biopsies with subcellular spatial resolution. The tech-
nology generates an image based on the AF intensity and time decay of
fluorophores, including NADH, flavins, porphyrins and elastin at dif-
ferent tissue depths.
For more specific ex vivo or in vitro AF measurements, particular
microscopes (e.g., Olympus IX71©) are used. Depending on their setup,
such microscopes allow high-resolution imaging of reflected or
Fig. 4. Flowchart reporting the selection procedures for papers on skin.
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transmitted fluorescence, by selecting the chosen excitation and emis-
sion bands, followed by digital image processing (Ericson et al., 2008).
Scout DS© (Veralight) performs a non-invasive automatic quanti-
tative fluorescence spectroscopy to detect the levels of advanced gly-
cation end products (AGEs) in the skin (Eny et al., 2015) of patients
with diabetes.
Among the optical components more frequently used in clinical
settings, the monochromator is a tunable optical filter that enables se-
lection and transmission of wavelengths of only a specific, narrow band
of the incident light (Gurushankar et al., 2015; Na et al., 2011; Nazeer
et al., 2014; Vedeswari et al., 2009). Such a device can be used to filter
narrow-band light, starting from a wide-band source to elicit tissue AF
(Breunig et al., 2010; Drakaki, Dessinioti, Stratigos, Salavastru, &
Antoniou, 2014; Gurushankar et al., 2015; Lane et al., 2006; Nazeer
et al., 2014; Na et al., 2011; Sandby-Møller et al., 2004; Vedeswari
et al., 2009; Yaroslavsky, Neel, & Anderson, 2004). A second mono-
chromator can be used to select the wanted emission narrow-band light
by removing the unwanted reflected excitation light. In some cases,
photomultiplier tubes, which are extremely sensitive detectors of light
signals, can be used (Breunig et al., 2010; Dimitrow, Riemann et al.,
2009, 2009b; Gurushankar et al., 2015; Krasieva et al., 2013; Leopold
et al., 2011; Nazeer et al., 2014; Vedeswari et al., 2009; Yu et al., 2012).
5. Discussion
Innovative, non-invasive visual tools, possibly improving diagnostic
accuracy, have recently gained interest. Among these, devices evalu-
ating tissues’ auto-fluorescence (AF) are emerging (Drakaki et al., 2014;
Giovannacci, Vescovi, Manfredi, & Meleti, 2016).
It seems likely that malignant or potentially malignant changes in
soft tissues may induce variations of the tissue AF spectra, which can be
visualised in real time by non-invasive methods.
On the basis of the present literature review, some evidence exists
that endogenous fluorophores of skin, stimulated by ultraviolet or blue
excitation wavelengths, are proteins such as collagen, elastin, keratin
and the amino acid tryptophan. On the other hand, the very limited
number of papers (5) investigated for fluorophores in the oral mucosa
does not allow drawing any robust conclusion on such an anatomical
compartment. Data on AF molecules in oral mucosa should, therefore,
be considered preliminary and presumptive, and they should be con-
firmed by further research.
Even though skin and oral mucosa share some similarities in terms
of overall histological architecture and molecule distribution, it should
be borne in mind that specific features (e.g., width of the keratin layer,
presence of peculiar glands, etc.) may be associated with different be-
haviours in terms of AF (light absorption and emission). Nevertheless, it
would seem that both in skin and oral mucosa, dysplastic and neoplastic
processes induce some alteration of fluorophores’ structure and/or
concentration, thus producing a variation of normal AF (Croce &
Bottiroli, 2014; Jayanthi et al., 2009).
Among fluorophores identified in the present review, localised ei-
ther in the oral mucosa or skin, there are molecules involved in tissue
metabolism such as the reduced forms of NAD (NADH) and NAD
phosphate (NADPH) and FAD. Metabolic activity of the relative
amounts of NADH, NADPH and FAD and the microenvironment of these
metabolic electron carriers can apparently be used to monitor changes
in metabolism non-invasively, which is one of the hallmarks of carci-
nogenesis (Gurushankar et al., 2015; Skala et al., 2007). Such coen-
zymes are the main ones responsible for AF rising from cell cytoplasm,
with their amount, redox and bound-free state in close relationship with
their engagement in energetic metabolism, cell oxidative defence, re-
ductive biosynthesis, and signal transduction (Croce & Bottiroli, 2014).
Particularly, NADH is more fluorescent than the oxidised form,
NAD+ (Miyamoto & Kudoh, 2013). Depending on the metabolic status
of cells (e.g., prevalence of reactions of oxidation or reduction), the
oxidised or reduced form of the coenzyme will be prevalent in the
cytoplasm, thus leading to a higher or lower degree of fluorescence
(Croce & Bottiroli, 2014). It has been widely demonstrated that neo-
plastic cells display an increase in oxidative processes, and it is there-
fore reasonable to hypothesise a shift in the NAD+/NADH equilibrium
toward a predominance of NAD+ (Drakaki et al., 2014; Gào &
Schöttker, 2017).
In addition, Drakaki et al., in their review on laser-induced fluor-
escence for diagnosis of basal cell carcinoma, confirmed that AF var-
iation in malignant tissues was caused by decreased NADH levels and
by a shifted equilibrium between the highly fluorescent NADH and the
less-fluorescent oxidised-form NAD+ (Drakaki et al., 2014).
Similar to NAD, NADP is fluorescent in its reduced form (NADPH);
the AF emission properties were strictly dependent on the bound/free
condition (Miyamoto & Kudoh, 2013). The typical energetic anaerobic
metabolism was observed in most neoplastic cells results, in general, in
lower values in the NADPH bound/free ratio with respect to non-neo-
plastic cells (Croce & Bottiroli, 2014; Salmon et al., 1982). Such a low
value of the bound/free ratio is, most probably, one of the biological
features associated to the loss of AF observed in tumour cells.
As part of the group of flavin free derivatives, FAD exhibits absorp-
tion/excitation and emission properties at 440–450 nm and 525 nm
(Penzer, 1980; Wolfbeiss, 1985). The fluorescence emission from FAD
has been reported to be strongly affected by the nature of the protein to
which the prosthetic group is bound (Kunz & Kunz, 1985; Kunz, 1986).
Interestingly, the first description of FAD fluorescence was performed in
1962, in intracellular granules of eosinophils (Grossi & Zaccheo, 1963).
It seems worthy to mention here that further studies demonstrated an
increase in AF amplitude and a shift from the blue to the yellow region
when the circulating cells settled in the tissues (Barnes, Aggarwal,
Thomsen, Fitzmaurice, & Richards-Kortum, 1992; Mayeno, Hamann, &
Gleich, 1992; Weil &, 1981).
Porphyrins are indicated as fluorophores both in oral mucosa and in
skin tissues, with an excitation wavelength of about 400 nm and
emission wavelength around 630–690 nm. Variation in porphyrin
concentration is considered an important marker for differentiating
malignant disorders from healthy tissues (Jayanthi et al., 2009). Ac-
cording to Bagri-Manjrekar et al., the mechanism responsible for such a
phenomenon seems to depend on one or more of the following possi-
bilities: (1) porphyrins of host origin and excreted from the circulating
blood by the tumour; (2) the tumour itself produces porphyrins and (3)
porphyrins are the product of microbial activity restricted to the ul-
cerated surface of the tumour (Bagri-Manjrekar et al., 2018).
In particular, Nazeer et al. demonstrated a more elevated level of
porphyrins in the tissues of patients with oral leukoplakia and among
tobacco users compared to non-tobacco users. Jayanthi et al. reported
that the level of porphyrins increases with the increase in pathological
grading, and Croce et al. reported that an excess of protoporphyrin IX
(PpIX) occurs naturally in cancers and their metastases (Croce et al.,
2011; Jayanthi, Subhash, Stephen, Philip, & Beena, 2011).
Interestingly, Inaguma et al. demonstrated that when exposed to
410 nm wavelength light, 85% of oral carcinomas returned porphyrin-
like fluorescence spectra, whereas the normal mucosa of the oral cavity
did not display such a feature (Inaguma & Hashimoto, 1999).
Moreover, the Mallia et al. study highlighted that the peak observed
at 685 nm, especially in neoplastic and dysplastic tissues, could depend
on the accumulation of the endogenous fluorophore coproporphyrin III,
which is a precursor of PpIX in the heme synthesis. This peak was ab-
sent in tissues from healthy volunteers, which confirmed such findings
(Mallia et al., 2008).
Among less-reported fluorophores, the present review identified
flavin, lipopigment, advanced glycation end products (AGEs), pheo-
melanin and eumelanin.
Zhao et al. reported flavin and lipopigment as endogenous fluor-
ophores of eccrine sweat glands. Following irradiation with a 488 nm
wavelength, a single eccrine sweat gland isolated from normal skin
tissue under a microscope showed AF with two peaks: 530 and 590 nm,
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corresponding to flavin and lipopigment peaks. Such molecules are
coenzymes in many metabolic pathways. AF measurement could
therefore be performed to monitor cells and tissue energy metabolism
(Zhao et al., 2016).
AGEs are a heterogeneous group of molecules resulting from non-
enzymatic glycation of proteins, lipids, and nucleic acids. The measure
of AGE residues provides information on glycemic control in diabetic
patients (Eny et al., 2015; Stirban et al., 2008). It would seem that their
concentration can be indirectly measured by evaluating skin AF. Stirban
et al., using an excitation light source between 300 and 420 nm, de-
monstrated that skin AF increases after lunch in both healthy and
diabetic patients (Stirban et al., 2008).
Light absorption behaviour of melanin is completely different from
the absorption of other organic fluorophores (Hoffmann, Stucker,
Altmeyer, Teuchner, & Leupold, 2001). In fact, melanin AF in the
spectral region of 450–650 nm is extremely weak in human skin tissue
and is completely hidden from the main endogenous fluorophores (e.g.,
NADPH e flavins) (Teuchner et al., 1999; Zeng, MacAulay, McLean, &
Palcic, 1995). Such a disadvantage has been overcome only recently, by
using special fluorescence techniques such as one-photon excitation and
two-photon absorption (Weinberger et al., 2006; Teuchner et al., 1999).
Upon irradiation with 800-nm laser pulses, melanin absorbs two pho-
tons in a stepwise process through an intermediate excited electronic
state (Teuchner et al., 1999).
The multiphoton laser tomography (MLT), developed on the basis of
the aforementioned technologies, enables a three-dimensional optical
sectioning with a subcellular spatial resolution, thus allowing selective
melanin imaging (Koenig & Riemann, 2003).
Investigation of melanin fluorescence, within a different set of
pigmented lesions of the skin, showed a marked difference in AF be-
haviour of benign pigmentations (e.g., melanocytic nevi) with respect
to melanoma (Hoffmann et al., 2001). Leupold et al. confirmed that
through the use of a two-photon excitation technology with 2.5-ns
pulses, melanin fluorescence peak is 590 nm in all types of benign
melanocytic nevi, although it shifts to red light with 640 nm in mela-
noma (Leupold et al., 2011). Such observation led to the hypothesis that
malignant transformation of melanocytes is associated with changes in
melanogenesis and in the amounts of cellular eumelanin and pheome-
lanin (Leupold et al., 2011).
The reason for the red-shift of melanin fluorescence in melanoma is
the modification of the eumelanin/pheomelanin ratio with an higher
concentration of pheomelanin in malignant lesions (Leupold et al.,
2011; Simon, Peles, Wakamatsu, & Ito, 2009; Yaroslavsky et al., 2004).
Dimitrow et al. further demonstrated that MLT can differentiate
between benign and malignant melanocytic lesions both in vivo and ex
vivo. In fact, among 83 pigmented lesions of the skin, the authors
highlighted distinct morphological differences in melanoma compared
with melanocytic nevi. In particular, six characteristic features of AF
malignant melanoma were specified (architectural disarray, pleo-
morphic cells, poorly defined keratinocyte cell borders, large inter-
cellular distance, ascending melanocytes and dendritic cells). The
technique showed an overall sensitivity of 75% in vivo and 93% ex vivo
(Dimitrow, Ziemer et al., 2009).
All clinical applications of oral mucosal AF reported in the papers
included in the present review were related to the diagnosis and follow-
up of malignant and potentially malignant lesions (Gurushankar et al.,
2015; Jayanthi et al., 2009; Lane et al., 2006; Vedeswari et al., 2009).
It should be borne in mind that a potential risk of malignant
transformation associated with the use of UV-emitting devices exists
(D’Orazio, Jarrett, Amaro-Ortiz, & Scott, 2013). Therefore, caution
should be used in clinical settings, when fluorescence is excited through
UV wavelengths. It would, however, seem improbable that the limited
time of exposure necessary in the reported techniques is sufficient to
generate some damage at the cellular and tissue levels.
AF detection in skin seems to cover a wider range of applications
than in oral mucosa. Several papers are focused on the diagnosis and
follow-up of malignant and potentially malignant lesions, both non-
melanoma skin cancers and melanoma. Skin AF has also been proposed
for assessing the severity of acne, for the diagnosis of sweat gland
pathologies, for monitoring glycemic control in diabetic patients and as
a marker for skin aging.
6. Conclusion
Some evidence exists for the usefulness of AF in the management of
potentially malignant and malignant lesions of the skin. On the other
hand, the very limited number of papers (5) investigating fluorophores
in oral mucosa, and their behaviour in physiologic and pathologic
conditions, does not allow any robust conclusions about such anato-
mical compartmentalisation. Further to diagnosis of malignant lesions,
potential fields of application of skin and mucosal AF have been ex-
plored. However, on the basis of the weak level of evidence, more well-
designed studies are needed to confirm such potentialities.
The heterogeneity of AF devices as well as their applications makes
it difficult to compare the results of the studies included in the present
review.
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